Anthony Polverino

2021 - Zymeworks

In 2021, Anthony Polverino earned a total compensation of $1.9M as Former Executive VP, Early Development & Chief Scientific Officer at Zymeworks, a 1% increase compared to previous year.

Compensation breakdown

Option Awards$1,178,164
Salary$440,800
Stock Awards$282,913
Other$16,031
Total$1,917,908

Polverino received $1.2M in option awards, accounting for 61% of the total pay in 2021.

Polverino also received $440.8K in salary, $282.9K in stock awards and $16K in other compensation.

Rankings

In 2021, Anthony Polverino's compensation ranked 6,192nd out of 12,415 executives tracked by ExecPay. In other words, Polverino earned more than 50.1% of executives.

ClassificationRankingPercentile
All
6,192
out of 12,415
50th
Division
Manufacturing
2,625
out of 5,505
52nd
Major group
Chemicals And Allied Products
1,145
out of 2,375
52nd
Industry group
Drugs
1,019
out of 2,096
51st
Industry
Pharmaceutical Preparations
737
out of 1,546
52nd
Source: SEC filing on November 25, 2022.

Polverino's colleagues

We found five more compensation records of executives who worked with Anthony Polverino at Zymeworks in 2021.

2021

Ali Tehrani

Zymeworks

Chief Executive Officer

2021

Neil Josephson

Zymeworks

Chief Medical Officer

2021

Neil Klompas

Zymeworks

Chief Financial Officer

2021

Diana Hausman

Zymeworks

Chief Medical Officer

2021

James Priour

Zymeworks

Former Chief Commercial Officer

News

In-depth

You may also like